Use of Atorvastatin as Adjuvant Therapy Among Suboptimal Responders to Antiretroviral Therapy in an African Cohort of HAART-Treated Adults: A Randomized Controlled Trial

torvastatin study at Makerere University College of Health Sciences to test the role of the drug on HIV-associated immune activation among suboptimal responders to antiretroviral therapy. The drug will help to improve immune recovery among HAART-treated HIV-patients in Africa.

Grant ID
ST-POC-0145-01
Show on Hub
On
Show on Spoke
Off
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
105415.00
Funding Currency
CAD
Exchange Rate (at time of payment)
0.7500000000
Funding Amount (in USD)
79061.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
79061.25
Co-Funded
False